Download  Print this page
   
1
2
Table of Contents
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460

Advertisement

18 Monitoring BIS

BIS Safety Information

For information on the use of BIS in specific monitoring situations and on pharmacological responses
to the anesthetic agents Nitrous Oxide (when used as the sole anesthetic agent), Ketamine, and
Etomidate, please contact Aspect Medical Systems to request a copy of their publication "A Clinician's
Guide to the Bispectral Index®".
Considerations for Use
Due to limited clinical experience in the following applications, BIS values should be interpreted
cautiously in patients with known neurological disorders, those taking psychoactive medications, and
in children below the age of 1.
WARNING
Conductive Parts: The conductive parts of sensors and connectors should not contact other
conductive parts, including earth.
High-frequency Surgery: To reduce the hazard of burns in the high-frequency surgical neutral
electrode connection, the BIS sensor should not be located between the surgical site and the electro-
surgical unit return electrode.
Defibrillation: The BIS sensor must not be located between defibrillator pads when a defibrillator is
used on a patient connected to the patient monitor.
Securing Cables: To minimize the risk of patient strangulation, the patient interface cable (PIC) must
be carefully placed and secured.
CAUTION
Revisions: The system will only function if all component revisions are compatible. Otherwise, an
incompatibility INOP is displayed.
If the DSC has an older software revision than the BIS Engine, the DSC will automatically be
upgraded by the BIS Engine. Do not disconnect the DSC from the BIS Engine, or disconnect the BIS
module from the monitor, or switch the monitor power off within the first ten seconds after
connection, as this will disrupt a possible software upgrade and cause damage to the DSC.
Impedance Checks: Impedance checks may influence data acquisition of other
electroencephalographic devices.
261

Advertisement

Table of Contents

Comments to this Manuals

Symbols: 0
Latest comments: